Midface lift Medical Services in China

Midface lift is a specialized cosmetic surgical procedure designed to restore youthful contour and volume to the central facial region—including the cheeks, lower eyelids, and nasolabial folds—by repositioning descended soft tissues and addressing age-related volume loss. Unlike traditional facelifts that focus on the lower face and neck, midface lifting targets the malar and suborbital zones, often employing either endoscopic, transblepharoplasty, or minimal-incision approaches to minimize scarring and downtime. It is commonly indicated for patients aged 40–65 experiencing midfacial ptosis, hollowing beneath the eyes, flattened cheekbones, or deepening of the tear trough and nasolabial groove—conditions not adequately corrected by fillers alone. The procedure may be performed standalone or in combination with blepharoplasty, fat grafting, or brow lift for comprehensive rejuvenation. Recovery typically spans 1–2 weeks, with final results emerging over 3–6 months as swelling resolves and tissues settle. While non-surgical alternatives exist, surgical midface lift offers longer-lasting, structural correction grounded in anatomical precision.

China offers compelling advantages for international patients seeking midface lift: highly competitive pricing (30–50% lower than the US or Western Europe), stringent national accreditation standards (e.g., JCI- and CNAS-certified hospitals), and seamless medical tourism infrastructure—including multilingual coordinators, visa support, and postoperative follow-up via telehealth. Chinese plastic surgeons are globally recognized for technical refinement in Asian facial anatomy, with extensive experience tailoring midface lifts to preserve ethnic harmony and avoid overcorrection. Leading centers such as Shanghai Ninth People’s Hospital and Beijing Plastic Surgery Hospital report >95% patient satisfaction rates and publish peer-reviewed outcomes demonstrating natural, long-term aesthetic improvement—supported by over 1,200 documented midface lift cases since 2018.

Treatment Options & Itemized Cost Breakdown: Mid-Face Lift (Plastic Surgery Department)

Non-Surgical / Conservative Options

*Target*: Mild to moderate mid-face volume loss and soft-tissue descent; patients seeking minimal downtime or contraindicated for surgery.

• •Hyaluronic Acid Fillers (e.g., Juvederm Voluma, Restylane Lyft)

- *Eligibility*: Healthy adults aged 35–65 with preserved skin elasticity, no active infection or severe autoimmune disease

- *Cost (per session)*: $420–$780 USD (¥3,000–¥5,600) — includes consultation, 1–2 mL product, and injection

• •Poly-L-lactic Acid (Sculptra)

- *Eligibility*: Patients requiring gradual, longer-lasting volumization (3–6 months); not suitable for immediate correction

- *Cost (per vial, 3-session course typical)*: $390–$650 USD/vial (¥2,800–¥4,700); full course: $1,170–$1,950 USD

• •Pre-Treatment Workup (mandatory for all injectables):

- Facial assessment + photography: $45 USD (¥320)

- CBC + coagulation panel: $32 USD (¥230)

Surgical / Procedural Options

*Department*: Plastic & Reconstructive Surgery (Grade 3A hospitals only). *Excludes ophthalmic procedures.*

• •Endoscopic Mid-Face Lift

- *Eligibility*: Ages 40–65; moderate mid-cheek descent, intact frontal bone attachment, no uncontrolled hypertension or anticoagulant use

- *Procedure Cost*: $4,200–$6,800 USD (¥30,000–¥49,000) — includes surgeon fee, anesthesia, facility, and 1-night stay

• •Subperiosteal Mid-Face Lift (Open Approach)

- *Eligibility*: Severe mid-face ptosis (>15 mm descent), prior failed non-surgical treatment, robust bone quality

- *Procedure Cost*: $7,200–$9,500 USD (¥52,000–¥69,000)

• •Preoperative Workup (required for all surgical candidates):

- CT maxillofacial (3D reconstruction): $185 USD (¥1,330)

- ECG + chest X-ray + comprehensive lab panel (liver/kidney function, HbA1c, INR): $125 USD (¥900)

Special / Complex Condition Management

• •Revision Mid-Face Lift (≥1 prior procedure): $8,100–$11,300 USD (¥58,500–¥82,000) — includes intraoperative navigation and extended OR time
• •Combined Mid-Face Lift + Autologous Fat Grafting: $9,400–$12,600 USD (¥68,000–¥91,500) — fat harvest, processing, and layered reinjection included
• •Diabetic or Hypertensive Patients (well-controlled, HbA1c <7.5%, BP <140/90): Additional pre-op cardiology clearance ($95 USD) and perioperative glucose/BP monitoring ($160 USD) required

Quick Selection Guide

• •Age <45, mild descent, budget <$1,000: Start with HA fillers ($420–$780) — lowest risk, reversible, natural results
• •Age 45–60, moderate descent, budget $4,000–$7,000: Endoscopic lift ($4,200–$6,800) — optimal balance of efficacy, recovery (~10 days), and safety
• •Age >60, severe descent + volume loss, comorbidities well-managed: Subperiosteal lift + fat grafting ($9,400–$12,600) — addresses structural deficiency and longevity
• •Contraindicated for surgery (e.g., anticoagulant dependence, advanced CVD): Sculptra course ($1,170–$1,950) — safest volumetric alternative with 2-year durability